RESPONSIBILITY

Inspiring New Understanding

At Halozyme, we are committed to doing the right thing in the right way. Our commitment to corporate citizenship is built on a foundation of integrity, respect and compassion.

Corporate Responsibility

Our Core Values drive this belief, as well as the commitments we make to our employees, our community, and the environment. What do these include?

View ESG Report

View ESG Key Data & Metrics

Employees

We provide, support, or sponsor:

A diverse and inclusive environment
Regular employee health and safety programs
Professional development for employees at all levels
Flexibility in working hours in support of work-life balance
Annual work-place safety training

Environment

Quarterly Safety Committee review of workplace safety and adherence to policies
Annual training in accordance with our Environmental, Health and Safety Policy, including commitment to safe disposal of all chemical waste

Governance and Ethics

Annual all employee training on our Code of Conduct
Confidential hotline and direct access to Chairman of Nominating & Governance Committee to report any compliance concerns via email at NGChair@Halozyme.com
Adherence to ICH, GCP, Declaration of Helsinki, GMP and GVP guidance
Commitment to data transparency through adherence to Clinical Trial Disclosure and Data Transparency requirements
Adherence to Good Publication Practice Guidelines
Commitment, including expectation for all vendors and partners, to affirm no use of child labor
Commitment to uphold Internationally recognized human rights

Community

We provide, support or sponsor:

Companywide community service days/volunteerism supporting:
STEM education
Humanitarian services (e.g., food drives, home builds, meal services)
Environmental organizations (e.g., lagoon cleanup events, park restoration)
Children/Military (e.g., school supply drives, holiday adopt-a-family, playhouse builds, paracord bracelets)
Cultural/diversity relations
Patient/healthcare advocacy groups

Diversity and Inclusion

As a leading biopharma company, we are building a diverse team who is passionate about and committed to having a positive impact on the lives of patients and their families around the world.

Gender

All Employees

67Female

69Male

Board of Directors

Sr. Director and Above

Race/Ethnicity

All Employees

59^%Caucasian or White

9^%Hispanic or Latino

4^%Black or African American

22^%Asian

2^%Native Hawaiian or other Pacific Islander

2^%Two or More

2^%Chose not to declare

Board of Directors

We value and celebrate the unique talents, backgrounds and perspectives each employee brings to the workplace. We also believe it is important to provide an environment where all employees are respected and rewarded for their contributions and can pursue their career goals in a supportive, team environment.

Our Principles

We have adopted the Biotechnology Innovation Organization’s principles on workforce development, diversity and inclusion, which are listed below:

Principal 1
We will champion workforce development, diversity and inclusion as a way to attract, develop and retain our talent pool within the globally competitive biotechnology industry.
Principal 2
We believe that diversity in all aspects of business operations will optimize the continued growth and success of our company and the biotechnology industry.
Principal 3
We will lead by example in our diversity efforts, and will incorporate diversity and inclusion into all aspects of our operations.
Principal 4
We will engage with external partners to broaden the reach and incorporation of diversity throughout the biotechnology ecosystem.
Principal 5
We believe our technologies and products should address the needs of a diverse population.

Governance

Halozyme has established a compliance reporting mechanism intended to supplement, not replace, other channels for communicating questions or concerns within the organization. A company independent of Halozyme staffs this hotline, which may be used anonymously to report violations or suspected violations of the law. The hotline may be accessed by calling 855-350-9391, online at http://www.halozyme.ethicspoint.com, or by directly contacting the Nominating and Corporate Governance Committee chairperson by e-mail at: info@halozyme.com.

Corporate Compliance

Halozyme Therapeutics, Inc. Annual Declaration pursuant to the California Health and Safety Code§§ 119400 -119402 (CA Senate Bill 1765)

Sections 119400-119402 of the California Health & Safety Code (“California Compliance Law”) requires a pharmaceutical company to adopt a Comprehensive Compliance Program that is in accordance with the U.S. Department of Health and Human Services, Office of Inspector General’s (“OIG”) “Compliance Program Guidance for Pharmaceutical Manufacturers” (“OIG Compliance Guidance”), and the PhRMA Code on Interactions with Healthcare Providers and any updates or revisions thereto (“PhRMA Code”). Further, the California Compliance Law requires that the Comprehensive Compliance Program include an annual limit for certain gifts or incentives given to healthcare professionals covered by the California Compliance Law. Finally, the California Compliance Law requires that each manufacturer make its Comprehensive Compliance Program and an annual declaration of compliance publicly available.

Halozyme Therapeutics, Inc. (“Halozyme”) has invested significant time and resources to the development of its policies, procedures and processes that make up its Comprehensive Compliance Program (the “Program”). In addition, the Program is intended to address the elements of an effective compliance program in accordance with the OIG Compliance Guidance and include policies for complying with the PhRMA Code. For purposes of compliance with the requirements of the California Compliance Law, the Program also includes an annual spend limit of $2,000 for gifts or incentives provided to healthcare professionals in California. The annual limit incudes the value of educational items, promotional materials and meals provided to healthcare professional in connection with business and educational discussions. The annual limits do not include the following: (a) drug samples given to physicians and healthcare professionals intended for free distribution to patients, financial support for continuing medical education forums, and financial support for health educational scholarships, provided that the support is provided in a manner that conforms to the OIG Compliance Guidance and the PhRMA Code, and (b) fair market value payments made for legitimate professional services provided by a health care or medical professional, including, but not limited to, consulting, provided that those payments are provided in a manner that conforms to the OIG Compliance Guidance and the PhRMA Code. This annual limit represents a spending cap and not a goal or average.

As stated in its Program description above, Halozyme is committed to conducting its business ethically and in compliance with all applicable laws. To the best of Halozyme’s knowledge, Halozyme believes it is in substantial compliance with its Compliance Program and in its good faith understanding of the requirements of the California law. Halozyme will update this declaration on an annual basis, as necessary.

Anyone wishing to obtain a copy of Halozyme’s Corporate Compliance Program Overview, the Code of Conduct or a copy of this Declaration can call 858.794.8889 or email info@halozyme.com.